Common Stock, $2 par value per share
- Symbol
- ACH
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Current Report · Items 5.02, 9.01 · 8-K/A
Accendra Health, Inc.
ACHNYSEEQUITYCurrent
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 22, 2026, Accendra Health and Mr. Gardner-Smith, the Company’s next President and Chief Executive Officer, mutually agreed to an effective start date of October 5, 2026. Edward A.…
Company context
Accendra Health, Inc. (NYSE: ACH) is a leading nationwide provider of products, technology, and services that support health beyond the hospital for millions of people each year. We connect patients, providers, and insurers, delivering innovative solutions that help promote better health outcomes and improve quality of life for people living with chronic, complex health conditions. Backed by the industry-leading expertise of our Apria and Byram brands, Accendra Health is reimagining the future of home-based care. To learn more about our broad portfolio of essentials for diabetes, sleep health, wound care, respiratory care, urology, and ostomy, visit www.accendrahealth.com.
Current securities
Recent company filings
- Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD DisclosureOct 9, 2026
- SCHEDULE 13G - filed by BANK OF AMERICA CORP /DE/ regarding ACCENDRA HEALTH INC/VA/Oct 7, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure · Other EventsSep 17, 2026
- 144 filingSep 11, 2026
- Regulation FD DisclosureAug 17, 2026
Registered securities in this filing
Accendra Health, Inc · 8-K/A · Filed 2026-09-28
Disclosure sections
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 22, 2026, Accendra Health and Mr. Gardner-Smith, the Company’s next President and Chief Executive Officer, mutually agreed to an effective start date of October 5, 2026. Edward A. Pesicka, who previously announced his intent to retire in August, will remain in the role of President and Chief Executive Officer until Mr. Gardner-Smith assumes the role on October 5, 2026, at which point Mr. Pesicka will also retire from the Board of Directors, as previously announced.
On September 28, 2026, Mr. Pesicka and the Company entered into a consulting agreement, under which Mr. Pesicka will serve as an advisor to the Company for up to thirty months to ensure a smooth transition. Under the consulting agreement, Mr. Pesicka’s previously awarded outstanding equity awards shall remain outstanding and shall continue to vest in accordance with their existing terms during the term of the consulting arrangement. Additionally, Mr. Pesicka will receive a COBRA benefit, as described in the consulting agreement.